GLOBUS MEDICAL INC Cash and Equivalents

Quick Answer

GLOBUS MEDICAL INC reported Cash and Equivalents of $526.16 million for fiscal year 2025.

GLOBUS MEDICAL INC Cash and Equivalents — Annual History

Fiscal Year Cash and Equivalents YoY Change
2025 $526.16M -32.9%
2024 $784.44M +301.3%
2019 $195.47M +40.0%
2018 $139.65M +17.5%
2017 $118.82M +77.5%
2016 $66.95M +16.1%
2015 $57.65M -29.9%
2014 $82.27M -8.6%
2013 $89.96M -57.6%
2012 $212.40M +48.9%
2011 $142.67M +27.7%
2010 $111.70M +120.5%
2009 $50.65M

Quarterly Cash and Equivalents

Quarter Ending Cash and Equivalents YoY QoQ
September 30, 2020 $250.61M +50.9% +51.4%
June 30, 2020 $165.55M +40.6% -0.7%
March 31, 2020 $166.74M +28.3% -14.7%
December 31, 2019 $195.47M +40.0% +17.7%
September 30, 2019 $166.09M +14.3% +41.0%
June 30, 2019 $117.79M -1.8% -9.4%
March 31, 2019 $129.98M +8.5% -6.9%
December 31, 2018 $139.65M +17.5% -3.9%
  • GLOBUS MEDICAL INC showed a decrease of -32.9% in Cash and Equivalents compared to the prior fiscal year.
  • Over the 2009–2025 period, GLOBUS MEDICAL INC’s cash and equivalents has grown by 938.8% (from $50.65 million to $526.16 million).
  • The most recent figure is from GLOBUS MEDICAL INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment